Deadline for hypoxic tumors

Moving personalized medicine from promise to practice. Siemens Healthcare announces the early study findings of a new imaging biomarker for hypoxic tumors. This clinically problematic cells tend to be less responsive to standard treatment regimens. A probe that measures hypoxia could prove quite a useful tool for oncologists.

Hypoxic cells are clinically problematic and tend to be less responsive to standard treatment regimens. A probe that measures hypoxia could prove quite a useful tool for oncologists. The development of an imaging biomarker that selectively identifies hypoxic tumor cells could help radiation oncologists tailor specific treatment options to most efficiently manage disease.

“Being able to image hypoxic tumors may significantly change the management of disease in cancer patients. The prognostic value of this level of information can effectively improve quality of life for oncology patients, offering them potential for personalized and possibly more effective treatment,” said Hartmuth Kolb, vice president, Siemens Molecular Imaging Biomarker Research.

The results of the safety study indicated that HX4, a new imaging biomarker developed at Siemens Molecular Imaging Biomarker Research, is safe for use in human positron emission tomography (PET) imaging studies. The study included initial human data regarding bio-distribution of the new agent, radiation dosimetry levels in normal volunteers and optimal patient imaging parameters with PET. Results of the study indicated that the compound was found to be stable for imaging at 145 minutes post injection, that it would safely clear the body through urinary elimination and that there were very low dose accumulations in major organs.

PETNET Solutions operates the largest PET radiopharmacy network with more than 50 radiopharmacies and distribution centers worldwide to produce and distribute PET radiopharmaceuticals to hospitals, clinics, and research facilities for PET imaging. PETNET Solutions is currently growing its network of radiopharmacies to promote global PET utilization. As molecular imaging evolves, PETNET Solutions delivers products and services that expand the value of PET to providers, referring physicians and patients. PETNET Solutions is delivering, expanding, and advancing the science of PET through high quality PET tracers. Further information can be found by visiting

www.petnetsolutions.com

.


 

19.09.2008

Read all latest stories

Related articles

Photo

Sponsored • Siemens Naeotom Alpha

First CT scanner with photon-counting technology

Conventional CT imaging has reached its technical limitations: Resolution can only be improved by small margins and dose cannot be reduced significantly: Photon-counting technology enables drastic…

Photo

Sponsored • Photon-counting CT scanner

No detours, more detail

For the Siemens Healthineers team developing new and ever higher performing computed tomographs is daily fare. But when they introduced their most recent CT system an unusual sense of pride was…

Photo

Siemens Healthineers and Flywheel

Partnership for healthcare research collaboration

Medical data management company Flywheel announced a partnership and enterprise license agreement with Siemens Healthineers. Under the agreement, Flywheel will deliver a cloud-based research…

Related products

Subscribe to Newsletter